EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS
Live / Registered — Registered (as of 11 Apr 2023)
What this means for you
Registered since 11 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97622958
- Registration number
- 7025936
- Mark type
- Stylized text
- Filed
- 07 Oct 2022
- Published for opposition
- 24 Jan 2023
- Registered
- 11 Apr 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Research and development of therapeutics for the treatment of neuromuscular, neurologic and other diseases; Research and development of peptide-conjugated therapeutics for the treatment of neuromuscular, neurologic and other diseases; Research and development of a drug delivery platform and conjugate therapeutics for the treatment of neuromuscular, neurologic and other diseases
Owner
- PepGen Inc., Cambridge, MA, US
- PepGen Inc., Cambridge, MA, US
- PepGen Inc., Cambridge, MA, US
Prosecution history
- 11 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 24 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Jan 2023 — PUBLISHED FOR OPPOSITION
- 04 Jan 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Dec 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Dec 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Dec 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Dec 2022 — NON-FINAL ACTION E-MAILED
- 02 Dec 2022 — NON-FINAL ACTION WRITTEN
- 01 Dec 2022 — ASSIGNED TO EXAMINER
- 24 Oct 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Oct 2022 — NEW APPLICATION ENTERED